Effect of prescription drug coverage on the elderly's use of prescription drugs

Inquiry

Volumn 46, Issue 1, 2009, Pages 33-45

  Khan, Nasreen ^a   Kaestner, Robert ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH INSURANCE; HUMAN; METHODOLOGY; MULTIVARIATE ANALYSIS; PRESCRIPTION; REGRESSION ANALYSIS;

EID: 66749101459     PISSN: 00469580     EISSN: None     Source Type: Journal    
DOI: 10.5034/inquiryjrnl_46.01.33     Document Type: Article

References (30)

1. Allison, P., and R. Waterman. 2000. Fixed Effects Negative Binomial Regressions Models. http:// www.ssc.upenn.edu/∼allison/FENB.pdf.
2. Blustein, J. 2000. Drug Coverage and Drug Purchases by Medicare Beneficiaries with Hypertension. Health Affairs19(2):219-230.
3. Booske, B. C., J. Lynch, and G. Riley. 2002. Impact of Medicare Managed Care Market Withdrawal on Beneficiaries. Health Care Finance Review24(1):95-115.
4. Briesacher, B. A., B. Stuart, J. Doshi, et al. 2005. Medicare Beneficiaries and the Impact of Gaining Prescription Drug Coverage on Inpatient and Physician Spending. Health Services Research40(5 Pt 1):1279-1296.
5. Bruen, B. K., J. M. Wiener, J. Kim, et al. 1999. State Usage of Medicaid Coverage Options for Aged, Blind and Disabled People. Washington, D.C.: The Urban Institute Press.
6. Bruen, B. K., J. M. Wiener, and S. Thomas. 2003. Medicaid Eligibility Policy for Aged, Blind, and Disabled Beneficiaries. Washington, D.C.: The Urban Institute Press.
7. Cameron, A. C., and P. K. Trivedi. 1998. Regression Analysis of Count Data. New York: Cambridge University Press.
8. Centers for Medicare and Medicaid Services (CMS). 2000. Medicare Current Beneficiary Survey. http://www.cms.hhs.gov/MCBS/.
9. Chandra, A., J. Gruber, and R. McKnight. 2007. Patient Cost-sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly. National Bureau of Economic Research (NBER) working paper no. 12972. Cambridge, Mass.: NBER.
10. Cutler, D. M., and R. J. Zeckhauser. 2000. The Anatomy of Health Insurance. In Handbook of Health Economics, A. J. Culyer and J. P. Newhouse, eds. North Holland: Elsevier.
11. Federman, A. D., A. S. Adams, D. Ross-Degnan, et al. 2001. Supplemental Insurance and Use of Effective Cardiovascular Drugs among Elderly Medicare Beneficiaries with Coronary Heart Disease. Journal of the American Medical Association286(14):1732- 1739.
12. Hoadley, J., E. Hargrave, J. Cubanski, et al. 2008. Medicare Prescription Drug Plans in 2008 and Key Changes since 2006: Summary of Findings. Washington, D.C.: Kaiser Family Foundation Press.
13. Hsu, J., M. Price, J. Huang, et al. 2006. Unintended Consequences of Caps on Medicare Drug Benefits. New England Journal of Medicine354(22):2349- 2359.
14. Johnson, R. E., M. J. Goodman, M. C. Horn-brook, et al. 1997. The Effect of Increased Prescription Drug Cost-sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members. Medical Care35(11):1119-1131.
15. Kaiser Family Foundation (KFF). 2002. The Current State of Retiree Health Benefits. Findings from the Kaiser/Hewitt 2002 Retiree Health Survey. Washington, D.C.: Kaiser Family Foundation Press. Laschober, M. A., M. Kitchman, P. Neuman, et al. 2002. Trends in Medicare Supplemental Insurance and Prescription Drug Coverage, 1996-1999. Health AffairsWeb Exclusive (suppl):W127-W138.
16. Lichtenberg, F. R., and S. X. Sun. 2007. The Impact of Medicare Part D on Prescription Drug Use by the Elderly. Health Affairs26(6):1735-1744.
17. Lillard, L. A., J. Rogowski, and R. Kington. 1999. Insurance Coverage for Prescription Drugs: Effects on Use and Expenditures in the Medicare Population. Medical Care37(9):926-936.
18. Pauly, M. V. 2004. Medicare Drug Coverage and Moral Hazard. Health Affairs23(1):113-122.
19. Pizer, S. D., and A. B. Frakt. 2002. Payment Policy and Competition in the Medicare+ Choice Program. Health Care Financing Review24(1):83-94.
20. Schneider, A., K. Fennel, and P. Keenan. 1999. Medicaid Eligibility for the Elderly. Kaiser Commission on Medicaid and the Uninsured. Washington, D.C.: Kaiser Family Foundation Press.
21. Shea, D. G., J. V. Terza, B. C. Stuart, et al. 2007. Estimating the Effects of Prescription Drug Coverage for Medicare Beneficiaries. Health Services Research42(3 Pt 1):933-949.
22. Soumerai, S. B., D. Ross-Degnan, J. Avorn, et al. 1991. Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes. New England Journal of Medicine325(15):1072-1077.
23. Stone, J., and H. G. Yacker. 2002. Prescription Drug Coverage for Medicare Beneficiaries: Medicaid and State Pharmaceutical Assistance Programs. Report for Congress.
24. Stuart, B. 2008. Where Are the Medicare Part D Claims Data? Annals of Internal Medicine148(3):239-240.
25. Stuart, B., D. G. Shea, and B. Briesacher. 2001. Dynamics in Drug Coverage of Medicare Beneficiaries: Finders, Losers, Switchers. Health Affairs20(2):86-99.
26. Stuart, B., and C. Zacker. 1999. Who Bears the Burden of Medicaid Drug Co-payment Policies? Health Affairs(March/April):201-212.
27. U.S. Department of Health and Human Services (DHHS). 2000. Prescription Drug Coverage, Spending, Utilization and Prices: Report to the President. Washington, D.C.: DHHS.
28. Wooldridge, J. 1999. Distribution-free Estimation of Some Nonlinear Panel Data Models. Journal ofEconometrics90(1):77-97.
29. Yang, Z., D. B. Gilleskie, and E. C. Norton. 2004. Prescription Drugs, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics. NBER working paper no. 10964. Cambridge, Mass.: NBER.
30. Yin, W., A. Basu, J. X. Zhang, et al. 2008. The Effect of Medicare Part D Prescription Drug Benefit on Drug Utilization and Expenditures. Annals of Internal Medicine148:169-177.